Let’s talk about the popular Express Scripts Holding Company (NASDAQ:ESRX). The company’s shares saw a decent share price growth in the teens level on the NasdaqGS over the last few months. As a large ...
You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...
Express Scripts Holding Company (NASDAQ: ESRX) will report its first quarter financial results on Tuesday, after the bell. A look at Estimize provides a picture of what to expect. The company guided ...
Steel Dynamics (STLD) Down 3.2% Since Last Earnings Report: Can It Rebound? Steel Dynamics (STLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for ...
They're the two biggest pharmacy benefits managers in the world, and they compete against each other every day. While CVS Health boasts a higher market cap thanks to its retail pharmacies, Express ...
Axios posted a template for a contract between Express Scripts, the country's largest pharmacy benefits manager, and its clients. On Tuesday, Express Scripts demanded it be taken down, citing ...
Express Scripts Holding (NAS: ESRX) is expected to report Q2 earnings on July 29. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year quarter, ...
One week from now, national pharmacy benefit manager Express Scripts is expected to terminate its coverage with locally-owned Martella's Pharmacy. Our Emily Marines took a deeper dive into PBMs to ...
Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...
NEW YORK (Reuters) - Express Scripts Inc will buy health insurer WellPoint Inc's NextRx prescription business for $4.68 billion, becoming the No. 2 U.S. pharmacy benefit manager while gaining more ...
The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly expands access to millions of commercially insured patients, improving availability of life-saving allergy ...